Mark Hopman, Chief Commercial Officer of Beta Bionics, Inc., filed a Form 4 on November 4, 2026, disclosing a sale of 370 shares of common stock on November 2, 2026, pursuant to a Rule 10b5-1 plan.

Key Highlights

  • Reporting person: Mark Hopman, Chief Commercial Officer of Beta Bionics, Inc. (NASDAQ:BBNX)
  • Transaction: 370 shares of common stock disposed of (transaction code S) on November 2, 2026
  • Sale price: $16.9 per share
  • Remaining holdings: 54,143 shares of common stock held directly following the transaction
  • 10b5-1 plan: The sale was made pursuant to a Rule 10b5-1 plan adopted on June 10, 2026
  • Filing date: November 4, 2026, signed by Thomas Sohn as Attorney-in-Fact

Hopman's November 2026 Common Stock Sale Under Scheduled 10b5-1 Plan

According to the Form 4 filed with the U.S. Securities and Exchange Commission on November 4, 2026, Mark Hopman, serving as Chief Commercial Officer of Beta Bionics, Inc. (NASDAQ:BBNX), reported the disposal of 370 shares of common stock on November 2, 2026, at a price of $16.9 per share. The filing notes the transaction was coded "S," indicating a sale, and was conducted directly by the reporting person.

The filing discloses that the shares were sold pursuant to a Rule 10b5-1 plan adopted on June 10, 2026. The form indicates this by way of a checked box stating the transaction was made "pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c)." Following the reported transaction, Hopman directly held 54,143 shares of Beta Bionics common stock, according to the filing.

No derivative securities transactions were reported in Table II of the filing. The Form 4 was signed by Thomas Sohn as Attorney-in-Fact on November 4, 2026. No amendment date was listed, indicating this is an original filing.

What Was Disclosed

Beta Bionics Chief Commercial Officer Mark Hopman disclosed the sale of 370 shares of common stock at $16.9 per share on November 2, 2026, under a pre-established Rule 10b5-1 plan, leaving him with 54,143 shares held directly.